Zheng X, Lau K, Frazier M, Cassell G H, Watson H L
Department of Microbiology, University of Alabama, Birmingham Schools of Medicine and Dentistry 35294, USA.
Clin Diagn Lab Immunol. 1996 Nov;3(6):774-8. doi: 10.1128/cdli.3.6.774-778.1996.
One of the major surface structures of Ureaplasma urealyticum recognized by antibodies of patients during infection is the MB antigen. Previously, we showed by Western blot (immunoblot) analysis that any one of the anti-MB monoclonal antibodies (MAbs) 3B1.5, 5B1.1, and 10C6.6 could block the binding of patient antibodies to MB. Subsequent DNA sequencing revealed that a unique six-amino-acid direct tandem repeat region composed the carboxy two-thirds of this antigen. In the present study, using antibody-reactive peptide scanning of this repeat region, we demonstrated that the amino acids defining the epitopes for MAbs 3B1.5 5B1.1 and 10C6.6 are EQP, GK, and KEQPA, respectively. Peptide scanning analysis of an infected patient's serum antibody response showed that the dominant epitope was defined by the sequence PAGK. Mapping of these continuous epitopes revealed overlap between all MAb and patient polyclonal antibody binding sites, thus explaining the ability of a single MAb to apparently block all polyclonal antibody binding sites. We also show that a single amino acid difference in the sequence of the repeats of serovars 3 and 14 accounts for the lack of reactivity with serovar 14 of two of the serovar 3-specific MAbs. Finally, the data demonstrate the need to obtain the sequences of the mba genes of all serovars before an effective serovar-specific antibody detection method can be developed.
解脲脲原体感染期间患者抗体识别的主要表面结构之一是MB抗原。此前,我们通过蛋白质免疫印迹(免疫印迹)分析表明,抗MB单克隆抗体(MAb)3B1.5、5B1.1和10C6.6中的任何一种都可以阻断患者抗体与MB的结合。随后的DNA测序显示,一个独特的六氨基酸直接串联重复区域构成了该抗原的羧基三分之二。在本研究中,通过对该重复区域进行抗体反应性肽扫描,我们证明了定义MAb 3B1.5、5B1.1和10C6.6表位的氨基酸分别为EQP、GK和KEQPA。对一名感染患者血清抗体反应的肽扫描分析表明,主要表位由序列PAGK定义。这些连续表位的定位揭示了所有MAb和患者多克隆抗体结合位点之间的重叠,从而解释了单个MAb显然能够阻断所有多克隆抗体结合位点的能力。我们还表明,血清型3和14重复序列中的单个氨基酸差异导致血清型3特异性MAb中的两种与血清型14缺乏反应性。最后,数据表明在开发有效的血清型特异性抗体检测方法之前,需要获得所有血清型的mba基因序列。